TagNovavax

#MSCOVID19: backing another winner

Good news! Another UK-backed COVID-19 vaccine, developed by Novavax, proves to be a winner with a point estimate of vaccine efficacy of 89.3% and no cases of severe COVID-19 in those who received the actual vaccine. The vaccine also works against the UK and South African variants of the virus. This vaccine is important because it is based on using a recombinant form of the spike protein produced...

Translate

Categories

Recent Posts

Recent Comments

Archives